Indegene

Market Cap: Small Cap
Industry: Healthcare Services
ISIN: INE065X01017
NSEID: INDGN
BSEID: 544172
View on NSE | View on BSE

INR

488.35

7.55 (1.57%)

BSENSE

Feb 06

BSE+NSE Vol: 1.97 lacs

{
  "main_header": {
    "sid": 10039241,
    "name": "Indegene",
    "stock_name": "Indegene",
    "full_name": "Indegene Ltd",
    "name_url": "stocks-analysis/indegene",
    "exchange": 0,
    "exchangecode": "",
    "country_id": 34,
    "currency": "INR",
    "cmp": "488.35",
    "chg": 7.55,
    "chgp": "1.57%",
    "dir": 1,
    "prev_price": "480.80",
    "mcapval": "11,570.00 Cr",
    "mcap": "Small Cap",
    "scripcode": 544172,
    "symbol": "INDGN",
    "ind_name": "Healthcare Services",
    "ind_code": 57,
    "indexname": "",
    "isin": "INE065X01017",
    "curr_date": "Feb 06",
    "curr_time": "",
    "bse_nse_vol": "1.97 lacs",
    "exc_status": "Active",
    "traded_date": "Feb 06, 2026",
    "traded_date_str": "2026 02 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/indegene-10039241-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-amid-mixed-market-signals-3823729",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndegeneLtd_technicaldot_3823729.png",
        "date": "2026-02-06 08:03:50",
        "description": "Indegene Ltd has experienced a subtle yet notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.61% to close at ₹482.90, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. Investors and analysts are closely monitoring these developments as the healthcare services company navigates a challenging market environment."
      },
      {
        "title": "Indegene Ltd is Rated Hold by MarketsMOJO",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/indegene-ltd-is-rated-hold-by-marketsmojo-3820263",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndegeneLtd_mojoScore_3820263.png",
        "date": "2026-02-04 10:11:59",
        "description": "Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 February 2026, providing investors with an up-to-date view of the company’s performance and outlook."
      },
      {
        "title": "Indegene Ltd Technical Momentum Shifts Amid Mixed Market Returns",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-amid-mixed-market-returns-3819872",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndegeneLtd_technicaldot_3819872.png",
        "date": "2026-02-04 08:07:50",
        "description": "Indegene Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent uptick in price, the overall technical landscape suggests caution for investors as multiple metrics reflect weakening momentum in the healthcare services stock."
      },
      {
        "title": "Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-technical-momentum-shifts-amid-mixed-market-signals-3817332",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/2/IndegeneLtd_technicaldot_3817332.png",
        "date": "2026-02-03 08:05:48",
        "description": "Indegene Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a recent 1.55% gain in daily price, the stock faces mixed signals from key momentum and trend indicators, suggesting cautious optimism for investors in the healthcare services sector."
      },
      {
        "title": "Indegene Ltd Gains 1.73%: 4 Key Factors Driving the Week’s Volatility",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-gains-173-4-key-factors-driving-the-weeks-volatility-3812331",
        "imagepath": "",
        "date": "2026-01-31 09:03:14",
        "description": "    <div class=\"article-news-new\">\n        <div class=\"article-container\">\n\n<div class=\"article-content\">\n                <div class=\"highlight-box\">\n                    <h3>Key Events This Week</h3>\n                    <p><strong>27 Jan:</strong> Stock hits 52-week and all-time low near Rs.462</p>\n                    <p><strong>29 Jan:</strong> Q2 FY26 results reveal margin compression despite revenue growth</p>\n                    <p><strong>30 Jan:</strong> Stock falls again to 52-week low of Rs.455.8 amid market pressure</p>\n                    <p><strong>30 Jan:</strong> Week closes at Rs.482.20 (+1.73%) outperforming Sensex</p>\n                </div>\n\n                <div class=\"stats-row\">\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.474.00</div></div>\n                    <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><di..."
      },
      {
        "title": "Are Indegene Ltd latest results good or bad?",
        "link": "https://www.marketsmojo.com/news/result-analysis/are-indegene-ltd-latest-results-good-or-bad-3811950",
        "imagepath": "",
        "date": "2026-01-30 19:28:59",
        "description": "Indegene Ltd's latest financial results for Q2 FY26 present a mixed picture. The company reported net sales of ₹804.20 crores, reflecting a sequential growth of 5.70% and a year-on-year increase of 17.09%. This marks the seventh consecutive quarter of positive revenue growth, indicating the company's ability to capture market share within the healthcare services sector. However, the net profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29%. \n\nProfitability metrics show a concerning trend, with the operating margin (excluding other income) contracting to 17.48% from 20.41% in the previous quarter, and the PAT margin decreasing to 12.70% from 15.30%. This margin compression suggests challenges in cost management, particularly as employee costs rose significantly, accounting for a larger proportion of revenue compared to prior periods. \n\nDespite these profitability challeng..."
      },
      {
        "title": "Indegene Ltd Falls to 52-Week Low of Rs.455.8 Amid Market Pressure",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-falls-to-52-week-low-of-rs4558-amid-market-pressure-3811435",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3811435.png",
        "date": "2026-01-30 11:28:59",
        "description": "Indegene Ltd, a key player in the Healthcare Services sector, witnessed its stock price decline to a fresh 52-week low of Rs.455.8 on 30 Jan 2026, marking a significant milestone in its recent trading performance. This new low reflects ongoing challenges in the stock’s trajectory despite some positive financial indicators."
      },
      {
        "title": "Indegene Ltd Q2 FY26: Margin Compression Overshadows Revenue Growth",
        "link": "https://www.marketsmojo.com/news/result-analysis/indegene-ltd-q2-fy26-margin-compression-overshadows-revenue-growth-3810207",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/Indegene_quaterlyResult_3810207.png",
        "date": "2026-01-29 21:04:03",
        "description": "Indegene Limited, a healthcare services provider with a market capitalisation of ₹11,366 crores, reported net profit of ₹102.10 crores for Q2 FY26, marking a sequential decline of 12.29% from ₹116.40 crores in Q1 FY26, though demonstrating year-on-year growth of 11.34% from ₹91.70 crores in Q2 FY25. The stock has reacted negatively to the results, trading at ₹467.25, down 1.72% from the previous close of ₹475.45, and now sits 27.01% below its 52-week high of ₹640.15."
      },
      {
        "title": "Indegene Ltd Stock Hits All-Time Low Amid Continued Downtrend",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/indegene-ltd-stock-hits-all-time-low-amid-continued-downtrend-3805919",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/1/IndegeneLtd_priceRelatedfactors_3805919.png",
        "date": "2026-01-27 11:04:40",
        "description": "Indegene Ltd’s stock has declined to an all-time low of Rs.462.3, marking a significant milestone in its recent performance. The healthcare services company has experienced a sustained downward trajectory, underperforming both its sector and broader market indices over multiple time frames."
      }
    ],
    "total": 191,
    "sid": "10039241",
    "stock_news_url": "https://www.marketsmojo.com/news/indegene-10039241"
  },
  "announcements": [
    {
      "caption": "Announcement under Regulation 30 (LODR)-Earnings Call Transcript",
      "datetime": "04-Feb-2026",
      "details": "Transcript of earnings conference call on financial results for the quarter ended December 31 2025.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication",
      "datetime": "31-Jan-2026",
      "details": "Intimation of Newspaper Publication.",
      "source": "BSE"
    },
    {
      "caption": "Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome",
      "datetime": "30-Jan-2026",
      "details": "Audio Recording of the Q3FY26 Earnings Call.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Indegene Ltd has declared <strong>100%</strong> dividend, ex-date: 13 Jun 25",
          "dt": "2025-06-13",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "No <strong>Splits</strong> history available",
      "data": []
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "No <strong>Bonus</strong> history available",
      "data": []
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-06 08:03:50

Indegene Ltd has experienced a subtle yet notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook. Despite a modest day gain of 0.61% to close at ₹482.90, the stock’s technical indicators present a complex picture, reflecting mixed signals across weekly and monthly timeframes. Investors and analysts are closely monitoring these developments as the healthcare services company navigates a challenging market environment.

Read full news article

Indegene Ltd is Rated Hold by MarketsMOJO

2026-02-04 10:11:59

Indegene Ltd is rated 'Hold' by MarketsMOJO, with this rating last updated on 29 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 04 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.

Read full news article

Indegene Ltd Technical Momentum Shifts Amid Mixed Market Returns

2026-02-04 08:07:50

Indegene Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a transition from mildly bearish to bearish trends. Despite a recent uptick in price, the overall technical landscape suggests caution for investors as multiple metrics reflect weakening momentum in the healthcare services stock.

Read full news article

Indegene Ltd Technical Momentum Shifts Amid Mixed Market Signals

2026-02-03 08:05:48

Indegene Ltd has experienced a notable shift in its technical momentum, moving from a bearish stance to a mildly bearish outlook, reflecting a complex interplay of technical indicators. Despite a recent 1.55% gain in daily price, the stock faces mixed signals from key momentum and trend indicators, suggesting cautious optimism for investors in the healthcare services sector.

Read full news article

Indegene Ltd Gains 1.73%: 4 Key Factors Driving the Week’s Volatility

2026-01-31 09:03:14

Key Events This Week

27 Jan: Stock hits 52-week and all-time low near Rs.462

29 Jan: Q2 FY26 results reveal margin compression despite revenue growth

30 Jan: Stock falls again to 52-week low of Rs.455.8 amid market pressure

30 Jan: Week closes at Rs.482.20 (+1.73%) outperforming Sensex

Week Open

Rs.474.00

Week Close

Read full news article

Are Indegene Ltd latest results good or bad?

2026-01-30 19:28:59

Indegene Ltd's latest financial results for Q2 FY26 present a mixed picture. The company reported net sales of ₹804.20 crores, reflecting a sequential growth of 5.70% and a year-on-year increase of 17.09%. This marks the seventh consecutive quarter of positive revenue growth, indicating the company's ability to capture market share within the healthcare services sector. However, the net profit for the quarter was ₹102.10 crores, which represents a sequential decline of 12.29%. Profitability metrics show a concerning trend, with the operating margin (excluding other income) contracting to 17.48% from 20.41% in the previous quarter, and the PAT margin decreasing to 12.70% from 15.30%. This margin compression suggests challenges in cost management, particularly as employee costs rose significantly, accounting for a larger proportion of revenue compared to prior periods. Despite these profitability challeng...

Read full news article

Indegene Ltd Falls to 52-Week Low of Rs.455.8 Amid Market Pressure

2026-01-30 11:28:59

Indegene Ltd, a key player in the Healthcare Services sector, witnessed its stock price decline to a fresh 52-week low of Rs.455.8 on 30 Jan 2026, marking a significant milestone in its recent trading performance. This new low reflects ongoing challenges in the stock’s trajectory despite some positive financial indicators.

Read full news article

Indegene Ltd Q2 FY26: Margin Compression Overshadows Revenue Growth

2026-01-29 21:04:03

Indegene Limited, a healthcare services provider with a market capitalisation of ₹11,366 crores, reported net profit of ₹102.10 crores for Q2 FY26, marking a sequential decline of 12.29% from ₹116.40 crores in Q1 FY26, though demonstrating year-on-year growth of 11.34% from ₹91.70 crores in Q2 FY25. The stock has reacted negatively to the results, trading at ₹467.25, down 1.72% from the previous close of ₹475.45, and now sits 27.01% below its 52-week high of ₹640.15.

Read full news article

Indegene Ltd Stock Hits All-Time Low Amid Continued Downtrend

2026-01-27 11:04:40

Indegene Ltd’s stock has declined to an all-time low of Rs.462.3, marking a significant milestone in its recent performance. The healthcare services company has experienced a sustained downward trajectory, underperforming both its sector and broader market indices over multiple time frames.